Invest Now
Samco Star Rating Ads

Dr Reddys Laboratories Ltd Price Performance

  • Day's Low
  • ₹1,249.55
  • Day's High
  • ₹1,281
₹ 1,275.40
  • 52-w low
  • ₹1,094.24
  • 52-w high
  • ₹1,421.49
1,275.40
  • Day's open
    ₹1,251.90
  • Previous close
    ₹1,247.65
  • VWAP
    ₹1,274.47
  • Lower price band
    ₹1,122.90
  • Upper price band
    ₹1,372.40

Today's Market Action

The last traded share price of Dr Reddys Laboratories Ltd was 1,275.40 up by 2.22% on the NSE. Its last traded stock price on BSE was 1,277.90 up by 2.40%. The total volume of shares on NSE and BSE combined was 2,891,291 shares. Its total combined turnover was Rs 368.49 crores.

Dr Reddys Laboratories Ltd Medium and Long Term Market Action

Dr Reddys Laboratories Ltd hit a 52-week high of 1,421.49 on 21-08-2024 and a 52-week low of 1,094.24 on 21-12-2023. The stock price of Dr Reddys Laboratories Ltd is up by 7% over the last one month. Don't forget to check the full stock price history in the table below.

Dr Reddys Laboratories Ltd Fundamentals

  • Market Cap (Cr): 102354

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Dr Reddys Laboratories Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Dr Reddys Laboratories Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Dr Reddys Laboratories Ltd

Data not available.

Dr Reddys Laboratories Ltd FAQ's

What is Share Price of Dr Reddys Laboratories Ltd?

What is the Market Cap of Dr Reddys Laboratories Ltd?

What is PE Ratio of Dr Reddys Laboratories Ltd?

What is PB Ratio of Dr Reddys Laboratories Ltd?

What is the CAGR of Dr Reddys Laboratories Ltd?

How to Buy Dr Reddys Laboratories Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.

Cons

  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.57. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 191 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Green line
100
0%
0% People are bullish about Dr Reddys Laboratories Ltd
0%
0 % People are bearish about Dr Reddys Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Dr Reddys Laboratories Ltd

1,275.40 +27.75 (2.22%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91